Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
André Scheen, Fabrice Bonnet
Topics & Concepts
MedicineHeart failureDiabetes mellitusPopulationRelative riskDiseaseIncidence (geometry)Intensive care medicineCohort studyInternal medicineType 2 Diabetes MellitusCohortEnvironmental healthEndocrinologyConfidence intervalPhysicsOpticsDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes